Hepatobiliary and Pancreatic Neoplasms: Essential Predictive Imaging Features for Personalized Therapy.

Mariko Irizato1, Kiyoyuki Minamiguchi1, Tomoko Uchiyama1

  • 1From the Departments of Diagnostic and Interventional Radiology (M.I., K.M., H.K., T. Tachiiri, R.T., N.M., T. Tanaka) and Diagnostic Pathology (T.U.), Nara Medical University, Shijyocho 840, Kashihara, Nara 634-8522, Japan; Department of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, Aichi, Japan (M.I., Y.I.); and Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University Faculty of Health Sciences, Kanazawa, Japan (A.K.).

Summary

Radiomics, using CT and MRI, reveals tumor biologic characteristics for personalized cancer treatment. Radiologists can use these imaging findings to predict prognosis and treatment efficacy in hepatobiliary and pancreatic neoplasms.